White Papers / Tech Papers
Technology Selection for Bioavailability Enhancement
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
Released by
Lonza
09.14.20
More White Papers / Tech Papers by Lonza
More Content From Lonza
-
Discover how this scalable and robust technology can facilitate the development and manufacturing of your bioconjugate drug.
-
Learn more about the scale up of antibody drug conjugates payloads by viewing this webinar.
-
Lonza's Michiya Hayakawa provides an overview of the current market and presents strategies for manufacturing highly potent active drugs.